Highlights
- 1
- 2The Journal of international medical research · 2020
- 3
Publications
279 publications
Funding
4 grantsView NIH portfolio on RePORTER ↗
Active
1 grant- MPIR01CA254035-01CAR T Cells for Advanced Thyroid CancerNational Cancer Institute · 2021–2026 · via Houston Methodist Research Institute· 2 renewals
Completed grants (3)
- Co-I2023-ASEF-GR-1CESERT PYRAMID Giant Robot GrantAssociation for Surgical Education · 2023–2024
- PISRA 224214-02Proposed Studies for anti-CSPG4 ADC (ARD107) in Anaplastic Thyroid CancerArdeagen Corporation · 2022–2023Contract
- KPNANTS 190177-01Analysis of immune environment for targeting metastatic pancreatic neuroendocrine tumorsNorth American Neuroendocrine Tumor Society · 2019–2021No publications yet
Clinical research
3 studies
Active
2 studies- PINCT07287176Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System in Symptomatic Benign Thyroid Nodules (PRECISE-BTN)NA · Pulse Biosciences INC · OPEN TO ACCRUAL (as of 2025)Thyroid Nodule; Thyroid Goiter; Ablation
- PIScreening for Primary Aldosteronism according to Consensus Guidelines at The New York PresbyterianWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2021)
Completed & closed trials (1)
- PIMolecular Characterization of Patients with COVID-19 DiseaseWeill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2023)
Available technologies
1 technologyView full WCM portfolio ↗
External relationships
Ownership
Mediflix Inc.
Professional Services
Pulse Biosciences INC
Other Interest
Pulse Biosciences INC